Darla SandyKnowledge Contributor
How do emerging biomarkers contribute to precision cardiovascular risk assessment?
How do emerging biomarkers contribute to precision cardiovascular risk assessment?
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Login to our social questions & Answers Engine to ask questions answer people’s questions & connect with other people.
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Questions | Answers | Discussions | Knowledge sharing | Communities & more.
Emerging biomarkers, such as high-sensitivity C-reactive protein (hs-CRP), lipoprotein(a) [Lp(a)], and coronary artery calcium (CAC) score, provide additional insights into cardiovascular risk beyond traditional risk factors. Incorporating these biomarkers into risk assessment algorithms can improve risk prediction accuracy and identify individuals who may benefit from more aggressive preventive interventions.